Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
1.680
+0.250 (17.48%)
At close: Aug 13, 2025, 4:00 PM
1.850
+0.170 (10.12%)
After-hours: Aug 13, 2025, 7:55 PM EDT
Scinai Immunotherapeutics Market Cap
Scinai Immunotherapeutics has a market cap or net worth of $1.57 million as of August 13, 2025. Its market cap has decreased by -34.64% in one year.
Market Cap
1.57M
Enterprise Value
1.46M
1-Year Change
-34.64%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since May 12, 2015, Scinai Immunotherapeutics's market cap has decreased from $11.20M to $1.57M, a decrease of -85.99%. That is a compound annual growth rate of -17.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 12, 2025 | 1.20M | -58.62% |
Dec 31, 2024 | 2.90M | 31.82% |
Dec 29, 2023 | 2.20M | -60.00% |
Dec 30, 2022 | 5.50M | -83.68% |
Dec 31, 2021 | 33.70M | 5.64% |
Dec 31, 2020 | 31.90M | -65.85% |
Dec 31, 2019 | 93.40M | 199.36% |
Dec 31, 2018 | 31.20M | 72.38% |
Dec 29, 2017 | 18.10M | 60.18% |
Dec 30, 2016 | 11.30M | 0.89% |
Dec 31, 2015 | 11.20M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 574.04B |
Johnson & Johnson | 416.11B |
AbbVie | 350.91B |
UnitedHealth Group | 236.90B |
AstraZeneca | 232.33B |
Novartis AG | 230.64B |
Abbott Laboratories | 228.03B |
Novo Nordisk | 223.00B |